The current stock price of OMDA is 15.41 USD. In the past month the price increased by 0.65%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| CVS | CVS HEALTH CORP | 11.72 | 101.94B | ||
| CI | THE CIGNA GROUP | 9.82 | 74.52B | ||
| BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 124.05 | 22.82B | ||
| LH | LABCORP HOLDINGS INC | 15.92 | 20.88B | ||
| DGX | QUEST DIAGNOSTICS INC | 17.87 | 19.40B | ||
| GH | GUARDANT HEALTH INC | N/A | 14.19B | ||
| DVA | DAVITA INC | 12.07 | 7.87B | ||
| HIMS | HIMS & HERS HEALTH INC | 58.69 | 7.21B | ||
| BTSG | BRIGHTSPRING HEALTH SERVICES | 36.79 | 6.77B | ||
| CHE | CHEMED CORP | 20.2 | 6.29B | ||
| RDNT | RADNET INC | 205.79 | 6.03B | ||
| OPCH | OPTION CARE HEALTH INC | 21.34 | 5.05B |
Omada Health, Inc. engages in the provision of digital health services. The company is headquartered in South San Francisco, California and currently employs 849 full-time employees. The company went IPO on 2025-06-06. The firm has one operating segment, namely all virtual care program product offerings. The Company’s member-facing platform is designed to offer an integrated experience that encompasses the full range of direct interactions. The company offers range of programs like Omada for Prevention & Weight Health, Omada for Diabetes, Omada for Hypertension, Omada for musculoskeletal (MSK), and Omada GLP-1 Care Tracks. Its Omada for Prevention & Weight Health programs focus on prediabetes and weight management, two critical elements of preventing diabetes and heart disease. Its Omada for Diabetes program is designed to help members with type 1 or type 2 diabetes achieve stable blood glucose levels and meet and reach their goals for reducing hemoglobin A1C. Its Omada for Hypertension is designed to help reduce members blood pressure and help them maintain healthy blood pressure.
OMADA HEALTH INC
611 Gateway Blvd., Suite 120
South San Francisco CALIFORNIA US
Employees: 849
Phone: 18889878337
Omada Health, Inc. engages in the provision of digital health services. The company is headquartered in South San Francisco, California and currently employs 849 full-time employees. The company went IPO on 2025-06-06. The firm has one operating segment, namely all virtual care program product offerings. The Company’s member-facing platform is designed to offer an integrated experience that encompasses the full range of direct interactions. The company offers range of programs like Omada for Prevention & Weight Health, Omada for Diabetes, Omada for Hypertension, Omada for musculoskeletal (MSK), and Omada GLP-1 Care Tracks. Its Omada for Prevention & Weight Health programs focus on prediabetes and weight management, two critical elements of preventing diabetes and heart disease. Its Omada for Diabetes program is designed to help members with type 1 or type 2 diabetes achieve stable blood glucose levels and meet and reach their goals for reducing hemoglobin A1C. Its Omada for Hypertension is designed to help reduce members blood pressure and help them maintain healthy blood pressure.
The current stock price of OMDA is 15.41 USD. The price decreased by -6.27% in the last trading session.
OMDA does not pay a dividend.
OMDA has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
OMDA stock is listed on the Nasdaq exchange.
OMADA HEALTH INC (OMDA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.17).
OMADA HEALTH INC (OMDA) has a market capitalization of 892.39M USD. This makes OMDA a Small Cap stock.
ChartMill assigns a technical rating of 1 / 10 to OMDA.
ChartMill assigns a fundamental rating of 4 / 10 to OMDA. No worries on liquidiy or solvency for OMDA as it has an excellent financial health rating, but there are worries on the profitability.
Over the last trailing twelve months OMDA reported a non-GAAP Earnings per Share(EPS) of -1.17. The EPS increased by 30.18% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -22.64% | ||
| ROE | -29.94% | ||
| Debt/Equity | 0 |
16 analysts have analysed OMDA and the average price target is 29.48 USD. This implies a price increase of 91.29% is expected in the next year compared to the current price of 15.41.
For the next year, analysts expect an EPS growth of 69.33% and a revenue growth 52.16% for OMDA